Dow Up 0.51% Nasdaq Up 0.24%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.72 Down 0.03(0.67%) Nov 21, 4:00PM EST
Prev Close:3.75
Open:3.80
Bid:3.55 x 200
Ask:N/A
1y Target Est:6.75
Beta:-0.11
Next Earnings Date:N/A
Day's Range:3.67 - 3.80
52wk Range:3.04 - 6.17
Volume:368,955
Avg Vol (3m):691,374
Market Cap:346.45M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUDown 0.67%346.45M
BIIBUp 1.49%71.68B
GSKUp 0.04%111.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):75.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.52
Quarterly EPS Est (Dec-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback